Evidence map›Paper›PMID 35048271›Full record

ArticleMolecular biology reports2022

Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice.

Carolina Panzarin, Laís Angélica de Paula Simino, Mariana Camargo Silva Mancini, Leticia Martins Ignácio-Souza, Marciane Milanski, Márcio Alberto Torsoni, Adriana Souza Torsoni

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Carolina PanzarinLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Laís Angélica de Paula SiminoLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Mariana Camargo Silva ManciniLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Leticia Martins Ignácio-SouzaLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Marciane MilanskiLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Márcio Alberto TorsoniLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil.
Adriana Souza TorsoniLaboratory of Metabolic Disorders, School of Applied Sciences, University of Campinas - UNICAMP, 1300, Pedro Zaccaria St, Limeira, São Paulo, 13484-350, Brazil. atorsoni@unicamp.br.ORCID http://orcid.org/0000-0003-2287-7180
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 310129/2016-8Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/18321-6
6 · The paper itself

Abstract

introductionMetabolic alterations caused by an imbalance of macronutrient consumption are often related to the modulation of microRNAs (miRNAs), which could alter mRNAs expression profile and accelerate the development of non-alcoholic fatty liver disease (NAFLD).

aimsThis study aimed to investigate the contribution of miRNAs in modulating early stages of NAFLD in mice submitted to a high-fat diet (HFD). METHODS AND

resultsMale Swiss mice, fed either a control diet or an HFD for 1, 3, 7, 15, 30, 56 days, were assessed for metabolic alterations, gene expression and NAFLD markers. A hepatocyte cell line was used to investigate the effects of miR-370 modulation on enzymes involved in β-oxidation. Body weight and adiposity were higher after 7 days of HFD. Fasting glucose and insulin increased after 3 and 7 days of HFD, respectively. While hepatic lipid content increased from the first day on, hepatic glycogen had a decrease after 3 days of HFD consumption. miR-370 and Let-7 expression increased with acute and chronic exposure to HFD, accompanied by carnitine palmitoyltransferase 1A (Cpt1a), acyl-CoA dehydrogenase very long chain (Acadvl) and protein kinase AMP-activated Catalytic Subunit 2 (Prkaa2) downregulation, while decreased miR-122 expression was accompanied by 1-acylglycerol-3-phosphate-O-acyltransferase (Agpat) upregulation after 56 days of HFD consumption, some of them confirmed by in vitro experiments. Despite fluctuations in TNFa and IL6 mRNA levels, molecular modulation was consistent with hepatic TG and NAFLD development.

conclusionHepatic miR-370-122-Let7 miRNA modulation could be the first insult to NAFLD development, preceding changes in glycemic homeostasis and adiposity.

Indexed as

MicroRNAsNon-alcoholic Fatty Liver DiseaseAnimalsDiet, High-FatLiverMaleMiceMice, Inbred C57BLObesityMicroRNAsEpigeneticFatty liverInsulin resistanceObesity

Identifiers

PMID35048271
OpenAlexW4205904308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.